Your browser is no longer supported. Please, upgrade your browser.
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-3.83 Insider Own3.95% Shs Outstand1.09B Perf Week-4.80%
Market Cap10.83B Forward P/E4.05 EPS next Y2.45 Insider Trans-0.03% Shs Float1.05B Perf Month22.47%
Income-4012.00M PEG- EPS next Q0.62 Inst Own54.90% Short Float6.19% Perf Quarter33.33%
Sales17.46B P/S0.62 EPS this Y87.00% Inst Trans-7.52% Short Ratio3.09 Perf Half Y6.78%
Book/sh12.63 P/B0.79 EPS next Y2.51% ROA-6.80% Target Price8.89 Perf Year-51.04%
Cash/sh1.14 P/C8.73 EPS next 5Y-3.80% ROE-28.20% 52W Range6.07 - 20.34 Perf YTD-35.67%
Dividend- P/FCF- EPS past 5Y-28.50% ROI-3.20% 52W High-51.23% Beta1.85
Dividend %- Quick Ratio0.60 Sales past 5Y-1.50% Gross Margin42.60% 52W Low63.43% ATR0.50
Employees42535 Current Ratio0.90 Sales Q/Q-5.90% Oper. Margin-21.40% RSI (14)56.01 Volatility4.03% 5.50%
OptionableYes Debt/Eq1.95 EPS Q/Q-7.20% Profit Margin-23.20% Rel Volume0.58 Prev Close9.82
ShortableYes LT Debt/Eq1.73 EarningsNov 07 BMO Payout- Avg Volume20.99M Price9.92
Recom2.90 SMA20-0.67% SMA5016.87% SMA200-4.69% Volume12,257,916 Change1.02%
Nov-12-19Upgrade JP Morgan Underweight → Neutral $8
Oct-17-19Upgrade Gabelli & Co Hold → Buy
Aug-07-19Downgrade Evercore ISI Outperform → In-line
Jul-19-19Initiated Wolfe Research Peer Perform
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-10-19Resumed Credit Suisse Neutral
Jul-05-19Upgrade Argus Hold → Buy
Jun-11-19Initiated Barclays Underweight $8
Jun-03-19Upgrade Oppenheimer Perform → Outperform $12
May-30-19Downgrade BofA/Merrill Buy → Underperform
May-28-19Downgrade UBS Buy → Neutral
Mar-20-19Initiated SunTrust Hold
Mar-07-19Resumed UBS Buy $22
Mar-06-19Downgrade Morgan Stanley Overweight → Equal-Weight $17
Feb-20-19Downgrade Mizuho Buy → Neutral $25 → $18
Feb-14-19Upgrade Raymond James Mkt Perform → Outperform $22
Jan-23-19Upgrade UBS Neutral → Buy
Jan-23-19Upgrade Piper Jaffray Underweight → Neutral
Jan-03-19Upgrade BofA/Merrill Underperform → Buy
Nov-05-18Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-07-19 11:35AM  Did Hedge Funds Drop The Ball On Teva Pharmaceutical Industries Limited (TEVA) ? Insider Monkey
Dec-04-19 05:52PM  Bayer and Teva Double Down on Worst M&A Deals of Decade GuruFocus.com
09:00AM  Pfizer Stock Is A Top Pharma Company But Should You Buy It? Investor's Business Daily
08:20AM  Axsome Narcolepsy Candidate Meets Phase II Goal, Stock Up Zacks
07:59AM  J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders Zacks
Dec-03-19 09:38AM  Mylan (MYL) Launches Herceptin Biosimilar Ogivri in the US Zacks
Nov-27-19 12:36PM  Possible criminal probe undermines recovery in opioid stocks since global legal settlement announced MarketWatch +5.88%
09:37AM  Opioid Stocks Fall on News of Federal Criminal Investigation Barrons.com
07:34AM  Fed Reportedly Opens Criminal Investigation on Opioid Makers Zacks
06:56AM  IWH UK Midco Limited -- Moody's affirms IWH's (aka Theramex) B2 ratings; changes outlook to negative Moody's
06:14AM  Pharma Companies Shares Tank As Feds Investigate Opioid Crisis Benzinga
Nov-26-19 04:15PM  Opioid Epidemic: Feds Reportedly Launch Criminal Probe Into Drugmakers Investor's Business Daily -7.93%
04:11PM  Stock Market Live Updates: Markets close at record highs Yahoo Finance
03:58PM  4 Top Stock Trades for Wednesday: DIS, PANW, BURL, TEVA InvestorPlace
01:21PM  Shares of opioid makers and distributors drop on criminal probe MarketWatch
08:36AM  Generic Drugmakers Gain as Price-Fixing Probe Nears an End Zacks
07:08AM  Shares of generic drugmakers rise on hope that legal issues are nearing an end MarketWatch
Nov-25-19 03:21PM  Teva, Others in Talks With DOJ to End Generic Drug Probe Bloomberg
12:49PM  Shares of generic drugmakers jump in morning trading MarketWatch
08:35AM  Teva, Drugmakers in Talks With U.S. to End Generics Probes Bloomberg
08:00AM  Teva Announces Early Tender Results of its Debt Tender Offer and Election of Early Settlement Business Wire
06:06AM  [video]Teva, Generic Drugmakers Reportedly Aiming to Settle U.S. Antitrust Inquiry TheStreet.com
Nov-21-19 03:20PM  Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA Zacks
02:41PM  Biogen, Novartis named in settlement between foundation, federal prosecutors American City Business Journals
Nov-20-19 03:44PM  Charity to pay $4 million to resolve U.S. pharma kickback probe Reuters
03:32PM  Charity to pay $4 million to resolve U.S. pharma kickback probe Reuters
03:39AM  Corporate Bonds Are All the Rage in Emerging Markets Bloomberg
Nov-19-19 04:54PM  Teva, Bausch Could Be Next to File for Bankruptcy GuruFocus.com
01:21PM  Teva Announces Successful Upsize of Senior Notes Offering and Pricing of $2.1 Billion of Senior Notes Business Wire
Nov-18-19 09:01AM  Jazz's (JAZZ) Sleep Drug Sunosi Nears Approval in Europe Zacks
Nov-17-19 03:40PM  AbbVie's Humira on Pace to Become Biggest Seller by 2024 GuruFocus.com
Nov-15-19 03:05PM  Teva shares rise 9% MarketWatch +8.86%
Nov-14-19 01:55PM  Teva Pharmaceutical Industries Ltd -- Moody's rates Teva's new unsecured notes offering Ba2 Moody's
Nov-12-19 11:32AM  Tevas Links to Opioid Epidemic May Triple Funding Costs Bloomberg
10:47AM  Teva Vs. Amneal: JPMorgan Sees Hope For One, Decline For The Other Benzinga
09:30AM  Teva Pharmaceuticals Prospects Are Improving, Analyst Says. Hes Downbeat on a Rival. Barrons.com
08:37AM  Teva upgraded to neutral by J.P. Morgan MarketWatch
Nov-11-19 09:10AM  Is Teva Pharmaceutical Industries Ltd. (TEVA) a Great Value Stock Right Now? Zacks
Nov-08-19 09:59AM  Teva (TEVA) Q3 Earnings Miss, Stock Up on Guidance Increase Zacks +9.80%
09:44AM  Teva Announces $1.5 Billion Debt Tender Offers Business Wire
09:43AM  Teva Announces Launch of $1,500,000,000 Offering of Senior Notes Business Wire
09:38AM  With a Deal in Hand, Teva Stock Can Chart a Difficult Comeback InvestorPlace
08:14AM  5 Low Price-to-Book Stocks to Buy in November Zacks
Nov-07-19 04:29PM  This Pharma Giant Reported Lagging Earnings Here's Why Shares Rallied Investor's Business Daily
04:02PM  Teva shares rise as company offers reassurance on former flagship drug Copaxone MarketWatch
02:30PM  7 Stocks the Vanguard Health Care Fund Keeps Buying GuruFocus.com
02:05PM  Tevas CEO Says Opioid Deal Could Be Done By End of the Year Barrons.com
01:55PM  Teva Pharm says opioid settlement will not derail ability to cut debt Reuters
01:42PM  UPDATE 3-Teva Pharm says opioid settlement will not derail ability to cut debt Reuters
10:40AM  Teva and Other Opioid Defendant Stocks Jump on Strong Earnings Barrons.com
09:32AM  Teva (TEVA) Q3 Earnings Miss, Sales Top Estimates, Stock Up Zacks
08:25AM  Tevas Earnings Met Expectations, and the Stock Is on the Move Barrons.com
08:09AM  Teva Pharm says opioid settlement will not derail ability to cut debt Reuters
08:05AM  Teva's stock rises after profit and revenue miss expectations, but full-year guidance raised MarketWatch
07:20AM  Teva Pharm Q3 profit misses estimates, names new CFO Reuters
07:15AM  Teva and Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituximab) in the United States Business Wire
07:05AM  Teva Announces Appointment of New Chief Financial Officer Business Wire
07:00AM  Teva Reports Third Quarter 2019 Financial Results Business Wire
Nov-06-19 12:37PM  Teva earnings preview: Opioid suits are key MarketWatch -5.15%
06:30AM  Teva Reports Earnings Tomorrow. Heres What to Expect. Barrons.com
Nov-05-19 11:41AM  Mylan's (MYL) Q3 Earnings Beat Estimates, Revenues Miss Zacks
Nov-04-19 02:28PM  Sanofi settles 4-year legal battle over Genzyme drug for $315M American City Business Journals +5.39%
11:38AM  What's in the Cards for Teva (TEVA) This Earnings Season? Zacks
Nov-01-19 06:00PM  Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 (Updated Dial-in Information) Business Wire
Oct-31-19 05:45PM  Teva Pharmaceutical Industries Ltd. (TEVA) Dips More Than Broader Markets: What You Should Know Zacks
03:05PM  Virginia files opioid lawsuit against Teva and Cephalon American City Business Journals
08:54AM  Teva Canada Announces the Launch of a Bioequivalent Generic Version of Gilenya®, Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS) CNW Group
Oct-25-19 05:45PM  Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know Zacks
10:51AM  Lannett (LCI) to Report Q1 Earnings: What's in the Cards? Zacks
09:10AM  Should Value Investors Buy Teva Pharmaceutical Industries Ltd. (TEVA) Stock? Zacks
Oct-24-19 11:18AM  Johnson & Johnson Cut Its Earnings in a Late-Night Filing. Heres Why. Barrons.com
08:00AM  Teva to Present New Analyses of Fremanezumab and Country-Specific Burden of Migraine at 24th World Congress of Neurology Business Wire
06:00AM  Several states wary of $48 billion opioid settlement proposal Reuters
Oct-23-19 08:11PM  RPT-FOCUS-Tevas proposed opioid settlement could cost drugmaker pennies on the dollar Reuters
03:11PM  Tevas proposed opioid settlement could cost drugmaker pennies on the dollar Reuters
02:55PM  Tevas proposed opioid settlement could cost drugmaker pennies on the dollar Reuters
02:24PM  2 Sells and 1 Buy in Opioid Stocks InvestorPlace
10:01AM  Lilly (LLY) Q3 Earnings Top Estimates, Sales Lag, Stock Down Zacks
Oct-22-19 11:29AM  Hedge Funds Bailed Out of Teva Pharmaceutical Industries (TEVA) At the Right Time Insider Monkey
11:16AM  Teva Pharmaceutical Industries Ltd -- Moody's: Teva's proposed opioid framework credit negative, but cash outlays are modest Moody's
06:39AM  Dow Jones Futures: Stock Market Rally Nears Record Highs; Cadence Design, Vertex, Stamps.com, Opioid Settlement Make News Investor's Business Daily
Oct-21-19 06:56PM  October brings losses for short sellers in U.S. opioid-related shares Reuters +8.67%
06:12PM  Shapiro, state AGs announce tentative $48B national opioid settlement American City Business Journals
05:50PM  Drug Companies Strike $48 Billion Deal In Opioid Crisis With Four States Investor's Business Daily
04:18PM  Stocks close higher; Dows ascent clipped by Boeings slump MarketWatch
04:13PM  Drug Firms Ink Last-Minute $260 Million Deal Ahead Of Opioid Trial Investor's Business Daily
04:10PM  S&P 500 Climbs Beyond 3,000 on Trade; Bonds Fall: Markets Wrap Bloomberg
03:28PM  Teva Stock Jumps After the Company Reached a Tentative Opioid Deal Barrons.com
02:53PM  Teva shares jump about 10% on news of settlement with four states in opioid litigation MarketWatch
02:08PM  Major drug companies agree to pay $260 million settlement in opioid case MarketWatch
01:54PM  Four major players in the US opioid crisis reached a tentative deal in Ohio Quartz
01:53PM  Teva Settles Track 1 Opioid Cases and Reaches Agreement on Framework to Settle Remaining Litigation Business Wire
01:33PM  AmerisourceBergen, Teva part of $260M opioid litigation settlement deal American City Business Journals
01:03PM  Get Real. There Will Be a Global Opioid Settlement. Bloomberg
12:52PM  Teva Shares Higher After Drugmaker Proposes $23B Global Opioid Settlement TheStreet.com
12:24PM  J&J (JNJ) Recalls Baby Powder Batch as FDA Finds Asbestos Zacks
10:34AM  Q3 Earnings Reports to Flood Wall Street This Week Zacks
10:19AM  Opioid Settlement, Boeing Downgrades: Markets Looking Up Zacks
09:12AM  Drug Wholesalers, Teva Settle With Ohio Counties Over Opioids Bloomberg
09:08AM  4 Pharma Companies Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain Benzinga
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fridriksdottir HafrunExecutive VP, Global R&DDec 02Sale10.494,31045,21420,573Dec 03 06:32 AM
McClellan Michael JamesEVP, Chief Financial OfficerNov 05Sale8.832422,13815,898Nov 06 06:46 AM
Nazzi GianfrancoEVP, Growth Markets CommercialSep 18Sale7.829627,52310,678Sep 20 07:19 AM
O'Grady Brendan P.EVP, North America CommercialSep 18Sale7.834943,8692,135Sep 20 07:19 AM
McClellan Michael JamesEVP, Chief Financial OfficerSep 18Sale7.831,40611,01115,445Sep 20 07:17 AM
Griffin Deborah AChief Accounting OfficerSep 18Sale7.832,37618,6070Sep 20 07:12 AM
Daniell RichardExec. VP, European CommercialSep 18Sale7.821,1769,1971,676Sep 20 07:10 AM
Daniell RichardExec. VP, European CommercialSep 09Sale7.163332,384363Sep 11 06:58 AM
BARER SOL JDirectorJun 04Buy9.60104,5001,003,409220,442Jun 05 07:02 AM
BARER SOL JDirectorJun 03Buy8.98111,000997,013115,942Jun 03 11:21 AM
de Notaristefani CarloExecutive VP Global OperationsMay 20Sale11.4216,070183,51933,589May 21 06:38 AM
de Notaristefani CarloExecutive VP Global OperationsMay 16Sale11.766297,39718,784May 20 07:18 AM
O'Grady Brendan P.EVP, North America CommercialMar 18Sale16.631,17919,6011,388Mar 19 08:29 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 18Sale16.643205,3269,002Mar 19 08:17 AM
Daniell RichardExec. VP, European CommercialMar 18Sale16.641,29721,5880Mar 19 08:14 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 18Sale16.432,35838,7422,974Mar 19 08:11 AM
McClellan Michael JamesEVP, Chief Financial OfficerMar 18Sale16.632303,82412,760Mar 19 08:08 AM
Griffin Deborah AChief Accounting OfficerMar 18Sale16.6394315,6770Mar 19 08:06 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 18Sale16.633565,91916,750Mar 19 08:04 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 18Sale16.6363210,5079,149Mar 19 08:02 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 12Sale15.822,44438,6642,974Mar 14 07:44 AM
O'Grady Brendan P.EVP, North America CommercialMar 12Sale15.6773811,5681,388Mar 14 07:41 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 12Sale15.693255,0998,450Mar 14 07:36 AM
Griffin Deborah AChief Accounting OfficerMar 12Sale15.6795314,9380Mar 14 07:33 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 12Sale15.6764710,1428,602Mar 14 07:31 AM
Daniell RichardExec. VP, European CommercialMar 12Sale15.6971511,2180Mar 14 07:28 AM
O'Grady Brendan P.EVP, North America CommercialMar 04Sale16.881,16619,6861,388Mar 05 07:36 AM
McClellan Michael JamesEVP, Chief Financial OfficerMar 04Sale16.883636,12912,330Mar 05 07:28 AM
Griffin Deborah AChief Accounting OfficerMar 04Sale16.884,10769,3400Mar 05 07:23 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 04Sale16.884096,90516,094Mar 05 07:16 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 04Sale16.8860610,2318,058Mar 05 07:10 AM
Daniell RichardExec. VP, European CommercialMar 04Sale16.882,09835,4230Mar 05 07:05 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 04Sale16.885128,6457,892Mar 05 08:20 AM
Stark David MatthewExec. VP Chief Legal OfficerFeb 14Sale17.743,92669,6472,974Feb 19 07:26 AM
de Notaristefani CarloExecutive VP Global OperationsFeb 14Sale17.673,19256,39918,209Feb 19 07:05 AM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 14Sale17.671,84132,52915,338Feb 19 07:11 AM
de Notaristefani CarloExecutive VP Global OperationsFeb 13Sale17.885,04190,10812,121Feb 14 07:43 AM
Fridriksdottir HafrunExecutive VP, Global R&DJan 02Sale15.701,64325,79911,826Jan 03 07:24 AM